Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
2,6-SUBSTITUTED-4-MONOSUBSTITUTEDAMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
No-Receipt date
2012-03322 - 24/10/2012
No-Filing date
20120402399 - 24/10/2012
No-Granting date
3079223 - 29/10/2012
No-EPO application date
05812481.9 - 14/10/2005
No-EPO granting date
1891019 - 25/07/2012
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
10/2012 - 22/11/2012
Expiration date
15/10/2025
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US619272 P15/10/2004/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07D 413/04
C07D 409/04
C07D 403/04
C07D 239/46
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
345301
AVENTISUB LLC
3711 KENNETT PIKE, SUITE 200
GREENVILLE, DE 19807,U.S.A
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1032986
LIM, SUNGTAEK
1032987
HARRIS, KEITH JOHN
1032988
STEFANY, DAVID
1032989
GARDNER, CHARLES J.
1032990
CAO, BIN
1032991
BOFFEY, RAY ARGENTA DISCOVERY LTD.
1032992
GILLESPY, TIMOTHY A.
1032993
AGUIAR, JOACY, C.
1032994
HUNT, HAZEL J.
1032995
DECHAUX, ELSA A.
Representatives
Code
Firstname
Surname
Address
Town
Zip
3089
NIKOLAOS
LYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"
STOURNARI 37
ATHINA (ATTIKIS)
10682
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
7915
NIKOLAOS
LYMPERIS
STOURNARI 37
ATHINA (ATTIKIS)
10682
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
15/02/2013
Αλλαγή Διεύθυνσης Δικαιούχου (7e800)
ΑΡ. ΠΡΩΤ. 666/6-2-2013, ΚΩΔ. ΠΛΗΡ. 3090, ( ΜΕ ΤΗΝ ΥΠ'ΑΡΘ. USAV2003/0043/08.01.2013 ΚΟΙΝΟΠΟΙΗΣΗ ΤΟΥ ΕΓΔΕ)
434817 Aventis Pharmaceuticals Inc. 300 Somerset Corporate Boulevard ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bridgewater, NJ 08807
471513 Aventis Pharmaceuticals Inc. 55 Corporate Drive, ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bridgewater, NJ 08807
19/09/2016
Συγχωνεύσεις Εταιριών (7e803)
ΑΡ.ΠΡΩΤ.4594/26-08-16,ΔΝΥ921/14-9-16,ΚΩΔ.ΠΛΗΡ.3190
471513 Aventis Pharmaceuticals Inc. 55 Corporate Drive, ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bridgewater, NJ 08807
345301 Aventisub LLC 3711 Kennett Pike, Suite 200 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Greenville, DE 19807,U.S.A
Title Instruments
Date
Operation
Descreption
5/4/2018 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 04/2018 Αρ. Πρωτ. ΓΔ 1059 - 04/05/2018
Payments history
12 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).